Citations 762

O1‐04‐04: TDP‐43 mouse models: Tools toward understanding the normal and disease roles for TDP‐43

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2010.05.228

P2‐224: Gene expression analysis of TDP‐43 transgenic mice

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_12 | Pages: No page available

10.1016/j.jalz.2010.05.1273

P1‐292: Correlation between insulin‐degrading enzyme levels and neuropathology in control versus Alzheimer brains with and without cerebral amyloid angiopathy

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_9 | Pages: No page available

10.1016/j.jalz.2010.05.844

P1‐218: Mixed Alzheimer's and Lewy body disease pathology patterns

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_8 | Pages: No page available

10.1016/j.jalz.2010.05.769

P1‐185: Wild‐type human TDP‐43 induces mitochondrial abnormalities and axonal degeneration in transgenic mice

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_8 | Pages: No page available

10.1016/j.jalz.2010.05.735

P1‐179: Inducible expression of wild‐type TDP‐43 is toxic to mouse hippocampal and cortical neurons

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2010.05.729

P1‐102: Investigating cis‐SNP/mRNA level associations of candidate Alzheimer genes in different brain regions of patients and controls

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2010.05.651

P1‐095: Characterization of brain region‐ and disease‐specific IDE expression in Alzheimer patients and controls

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2010.05.643

P1‐058: Association of glyceraldehyde‐3‐phosphate dehydrogenase locus variant with late‐onset Alzheimer's disease

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_6 | Pages: No page available

10.1016/j.jalz.2010.05.606

IFN-γ Promotes Complement Expression and Attenuates Amyloid Plaque Deposition in Amyloid β Precursor Protein Transgenic Mice

The Journal of Immunology | April 5, 2010 | Volume: 184 | Issue: 9 | Pages: 5333-5343

10.4049/jimmunol.0903382 | PMID 20368278

Abstract Reactive gliosis surrounding amyloid β (Aβ) plaques is an early feature of Alzheimer’s disease pathogenesis and has been postulated to represent activation of the innate immune system in an apparently ineffective attempt to clear or neutralize Aβ aggregates. To evaluate the role of IFN-γ–mediated neuroinflammation on the evolution of Aβ pathology in transgenic (Tg) mice, we have expressed murine IFN-γ (mIFN-γ) in the brains of Aβ precursor protein (APP) Tg mice using recombinant adeno-associated virus serotype 1. Expression of mIFN-γ in brains of APP TgCRND8 mice results in robust noncell autonomous activation of microglia and astrocytes, and a concomitant significant suppression of Aβ deposition. In these mice, mIFN-γ expression upregulated multiple glial activation markers, early components of the complement cascade as well as led to infiltration of Ly-6c positive peripheral monocytes but no significant effects on APP levels, APP processing or steady-state Aβ levels were noticed in vivo. Taken together, these results suggest that mIFN-γ expression in the brain suppresses Aβ accumulation through synergistic effects of activated glia and components of the innate immune system that enhance Aβ aggregate phagocytosis.